Patents by Inventor Thomas O. Cameron

Thomas O. Cameron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240158494
    Abstract: The present disclosure provides anti-transferrin receptor antibodies, compositions comprising the same and methods of their use. This disclosure also provides polynucleotides and vectors encoding the anti-transferrin receptor antibodies and cells comprising the same, methods of making the antibodies, and molecules comprising the antibodies.
    Type: Application
    Filed: October 19, 2023
    Publication date: May 16, 2024
    Inventors: Isin Dalkilic-Liddle, Benjamin A. Smith, Karl J.M. Hanf, Fang Qian, R. Blake Pepinsky, Thomas O. Cameron
  • Patent number: 11827702
    Abstract: The present disclosure provides anti-transferrin receptor antibodies, compositions comprising the same and methods of their use. This disclosure also provides polynucleotides and vectors encoding the anti-transferrin receptor antibodies and cells comprising the same, methods of making the antibodies, and molecules comprising the antibodies.
    Type: Grant
    Filed: August 31, 2022
    Date of Patent: November 28, 2023
    Assignee: Biogen MA Inc.
    Inventors: Isin Dalkilic-Liddle, Benjamin A. Smith, Karl J. M. Hanf, Fang Qian, R. Blake Pepinsky, Thomas O. Cameron
  • Publication number: 20230131379
    Abstract: The present disclosure provides anti-transferrin receptor antibodies, compositions comprising the same and methods of their use. This disclosure also provides polynucleotides and vectors encoding the anti-transferrin receptor antibodies and cells comprising the same, methods of making the antibodies, and molecules comprising the antibodies.
    Type: Application
    Filed: August 31, 2022
    Publication date: April 27, 2023
    Inventors: Isin Dalkilic-Liddle, Benjamin A. Smith, Karl J. M. Hanf, Fang Qian, R. Blake Pepinsky, Thomas O. Cameron
  • Publication number: 20220089704
    Abstract: Featured are compositions comprising humanized and engineered variants of an antibody variable domain (e.g., FC5), chimeric molecules comprising same, compositions comprising same, and uses thereof.
    Type: Application
    Filed: October 28, 2019
    Publication date: March 24, 2022
    Inventors: Benjamin A. Smith, Andreas Lehmann, Thomas O. Cameron, R. Blake Pepinsky, Dingyi Wen, Graham K. Farrington, Gopalan Raghunathan, Nels E. Pederson, Danica Stanimirovic, Traian Sulea, Arsalan S. Haqqani